USPTO serial 90730431
TARGETED ANTIGEN LOADED LIPOSOME
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- ABID, NABEELA
- Law office
- TMO LAW OFFICE 301- EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with TARGETED ANTIGEN LOADED LIPOSOME?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
B. Anna McCoy
B. ANNA MCCOY MCCOY RUSSELL LLP1410 NW JOHNSON ST.STE. 201PORTLAND, OR 97209Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biomedical compounds, namely, peptide substrates used in analyzing and detecting cancer cells for clinical or medical laboratory use | ACTIVE | — |
| 005 | Synthetic peptides for medical use; synthetic peptides for medical use, namely, synthetic peptides for the treatment of cancer; pharmaceutical preparations for cancer treatments, namely, immunotherapeutic treatments for cancerous tumors; medical preparations, namely, pharmaceuticals containing lipids, liposomes, and peptides for use in the treatment of cancer | ACTIVE | — |
| 042 | Medical and pharmacological research services in the field of immunotherapy and cancer treatment; biological research, clinical research, and medical research all in the field of immunotherapies and cancer treatment; development of drug delivery agents being made from liposomes and peptides; development of drug delivery agents that facilitate the delivery of pharmaceuticals and pharmaceutical preparations | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SRI International
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named TARGETED ANTIGEN LOADED LIPOSOME
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 20, 2022 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 20, 2022 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 6, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 6, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 6, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 4, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 19, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 27, 2021 | NWAP | NEW APPLICATION ENTERED | — |